The multi-center study gathered outcomes from 53 patients with spondylotic radiculopathy who underwent cervical fusion using the DTRAX system.
Here are five takeaways:
1. Researchers found the DTRAX system reduced NDI, VAS neck pain, VAS arm pain, SF-12 PCS and SF-12 MCS.
2. The system didn’t impact lordosis following surgery.
3. The radiographic fusion rate was 98.1 percent.
4. The study recorded no device failure, implant lucency or surgical re-interventions.
5. Researchers concluded DTRAX technology may be a valuable option for surgeons treating patients with cervical radiculopathy.
“We believe that DTRAX technology fills critical gaps in the continuum of traditional cervical spine care,” said Jeff Smith, CEO, Providence Medical Technology.
More articles on devices:
Medtronic, Mazor Robotics, Xtant Medical & more: 18 key notes
Dr. Andrew Cooper 1st in the US to perform meniscus replacement using the NUsurface implant: 5 points
Global orthopedic devices market to increase 4.57% — 4 highlights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
